Welcome to our dedicated page for Tomi Environmental Solutions I news (Ticker: TOMZ), a resource for investors and traders seeking the latest updates and insights on Tomi Environmental Solutions I stock.
TOMI Environmental Solutions, Inc. reports developments tied to disinfection and decontamination products built around SteraMist iHP and Binary Ionization Technology. Company news commonly covers biocidal regulatory approvals, SteraMist applications in healthcare, life sciences, food safety, commercial facilities, transportation and remediation settings, and product categories such as BIT Solution consumables, integrated systems, mobile equipment and iHP Corporate Service offerings.
Updates also include operating and financial results, customer and service activity, training and application protocols, shareholder voting matters, governance topics, capital-structure disclosures and material agreements. TOMI's recurring business themes include the installed base for SteraMist delivery systems, consumable BIT Solution demand, engineered decontamination systems and professional decontamination services.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) has launched the SteraMist Integrated System - Standalone (SIS-SA), a revolutionary solution for cleanroom and laboratory decontamination. The SIS-SA addresses critical challenges in the Biological Safety Cabinets (BSCs) industry, offering reliable and efficient decontamination for BSCs and other small enclosed spaces.
The system simplifies daily disinfection in highly controlled environments, replacing labor-intensive and inconsistent processes. Multiple successful deployments in Q3 2024 highlight its potential as a cornerstone solution for high-standard disinfection environments. The growing BSC market, driven by pharmaceutical research, biotechnology, and healthcare sectors, presents a significant opportunity for the SIS-SA.
TOMI's COO, E.J. Shane, emphasized the SIS-SA's ability to solve persistent challenges for customers, ensuring consistent decontamination and helping facilities maintain compliance and operational efficiency.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced record Q3 2024 revenue for its iHP Corporate Service division, expecting approximately $650,000 for the three months ended September 30, 2024. This significantly surpasses historical averages of about $250,000 per quarter or $1 million annually. The growth reflects increased demand for TOMI's iHP services, particularly in the life sciences sector.
Key developments include:
- Expansion of market share in life sciences
- Multi-year service contracts with major clients like MD Anderson Cancer Center, LFB USA, and Pfizer
- Anticipated continued growth in service demand across multiple industries
TOMI plans to announce full Q3 financial results, including total revenue, on October 30th, 2024.
TOMI Environmental Solutions (NASDAQ: TOMZ), a global leader in disinfection and decontamination through its Binary Ionization Technology (BIT) platform under the SteraMist brand, announced its participation in the H.C. Wainwright 24th Annual Global Investment Conference. Elissa J. Shane, COO, and Joe Rzepka, CFO, will present on September 9, 2024, at 3:00 pm ET in the Roswell room, 4th Floor, at the Lotte New York Palace Hotel, NYC.
TOMI offers environmental solutions utilizing patented ionized Hydrogen Peroxide (iHP) technology, developed in collaboration with DARPA. Its versatile products serve various sectors, including hospitals, biosafety labs, and schools. The company will be available for one-on-one meetings throughout the conference. For more information, visit SteraMist or contact info@tomimist.com.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) has expanded its partnership with a global leader in laboratory testing and diagnostics services. The company received a $715,000 order for SteraMist mobile equipment and a Custom Engineered System (CES) to support the expansion of the client's Wisconsin facility. The order includes two mobile Environment Systems and a seven-applicator iHP CES system for three decontamination rooms.
TOMI's COO, Elissa J. Shane, highlighted the effectiveness of their SteraMist iHP technology in meeting the stringent demands of the life sciences sector. The company anticipates securing contracts with various institutions and expects growth within its custom and integration lines, which will drive recurring BIT-solution revenue.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) reported 170% sequential growth in Q2 2024 revenue, reaching $3,013,000 with break-even EPS. The company achieved profitability with a net income of $30,000, compared to a net loss in Q2 2023. Key highlights include:
- Operating income of $122,000
- Gross margin improvement to 61.5%
- 8.6% year-over-year revenue growth
- Strong mobile equipment sales, accounting for over 60% of revenue
- 31% increase in BIT Solution sales compared to Q2 2023
- 130% growth in international revenue
TOMI's CEO, Dr. Halden Shane, attributed the growth to revitalized revenue and cost reduction initiatives. The company's focus on expanding business development and improving shareholder value has led to nearly matching the entire 2023 mobile equipment sales in just the first half of 2024.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global disinfection and decontamination solutions company, has announced it will report its second quarter 2024 financial results on August 1, 2024, after market close. The company will hold a conference call at 4:30 p.m. ET the same day to discuss the results.
Investors can participate in the call by dialing (888) 506-0062 (US) or (973) 528-0011 (International). A live webcast will also be available on TOMI's Investor Relations website. A replay of the call will be accessible until August 15, 2024, using the replay access code: 50974.
TOMI specializes in environmental solutions for disinfection, utilizing its patented Binary Ionization Technology® (BIT™) platform, which uses a low percentage hydrogen peroxide as its active ingredient.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced preliminary unaudited revenue for Q2 2024. Revenue is expected to be approximately $3.0 million, a 10% increase year-over-year and a 170% increase sequentially. BIT Solution sales are projected to rise by about 31% year-over-year and 171% sequentially.
CEO Dr. Halden Shane attributes this growth to successful expansion of sales channels and customer base. The company's Custom Engineered Systems (CES) and SteraMist Hybrid solution are driving long-term growth. TOMI expects continued growth in the second half of 2024, aligning with analyst estimates. Full Q2 results are expected to be announced in early August 2024.
TOMI Environmental Solutions (NASDAQ: TOMZ) has secured a $1.2 million contract with Enviro-Mist Inc., a division of EMAQ Group, for the purchase of 20 SteraMist Environment Systems. This revenue will be recognized in Q2 2024. Enviro-Mist has joined TOMI's iHP Corporate Service team as an exclusive partner for the pharmaceutical market in the Western United States.
The partnership includes a multi-year contract for a single location of a long-standing customer, estimated to generate approximately $60,000 in annual BIT Solution sales. This strategic alliance aims to enhance SteraMist iHP technology's market penetration in the pharmaceutical industry, positioning TOMI for large-scale service sales and increased industry presence.
TOMI Environmental Solutions (NASDAQ: TOMZ) is collaborating with partners to combat the global avian influenza (H5N1) outbreak. Announced on June 13, 2024, the outbreak has affected 48 states and 50 jurisdictions, posing significant risks to poultry, dairy farms, and public health. TOMI's Binary Ionization Technology (BIT) and SteraMist products are being utilized to mitigate the spread of the virus. The company sees this as a strategic opportunity for growth in the food safety and agricultural sectors. CEO Dr. Halden Shane emphasizes the importance of advanced disinfection methods and biosecurity measures to ensure business continuity and animal health.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced two new purchase agreements with leading pharmaceutical companies. The first agreement involves a SteraMist Environment System and validation services for a major private pharmaceutical company in Mexico, marking an expansion of TOMI's global operations. The second agreement includes the sale of a SteraMist Hybrid System to BeSpoke Pharmaceuticals, a 503B product manufacturer in Nevada, valued at over $200,000. These deals highlight TOMI's strategic growth and market reach in the Life Sciences sector, underscoring their innovation and potential for long-term growth.